Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony Cheung

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
Scientific Reports|June 3, 2020
Rapid conjugation of antibodies to toxins to select candidates for the development of anticancer Antibody-Drug Conjugates (ADCs)Ricarda M Hoffmann, Silvia Mele, Anthony Cheung, et al.
Frontiers in Immunology|September 30, 2017
Functionally Active Fc Mutant Antibodies Recognizing Cancer Antigens Generated Rapidly at High YieldsKristina M Ilieva, Judit Fazekas-Singer, Daniela Y Achkova, et al.
Cell Reports|May 16, 2019
Integrin-Mediated Macrophage Adhesion Promotes Lymphovascular Dissemination in Breast CancerRachel Evans, Fabian Flores-Borja, Sina Nassiri, et al.
Scientific Reports|July 15, 2016
IgG subclass switching and clonal expansion in cutaneous melanoma and normal skinLouise Saul, Kristina M Ilieva, Heather J Bax, et al.
Journal for Immunotherapy of Cancer|June 11, 2021
Immunotherapy using IgE or CAR T cells for cancers expressing the tumor antigen SLC3A2Giulia Pellizzari, Olivier Martinez, Silvia Crescioli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 21, 2024
Anti-EGFR Antibody-Drug Conjugate Carrying an Inhibitor Targeting CDK Restricts Triple-Negative Breast Cancer GrowthAnthony Cheung, Alicia M Chenoweth, Annelie Johansson, et al.
Frontiers in Immunology|February 11, 2021
B Cells in Patients With Melanoma: Implications for Treatment With Checkpoint Inhibitor AntibodiesZena N Willsmore, Robert J Harris, Silvia Crescioli, et al.
Cell Reports|July 19, 2018
ALIX Regulates Tumor-Mediated Immunosuppression by Controlling EGFR Activity and PD-L1 PresentationJames Monypenny, Hanna Milewicz, Fabian Flores-Borja, et al.
European Journal of Immunology|January 15, 2021
Combined anti-PD-1 and anti-CTLA-4 checkpoint blockade: Treatment of melanoma and immune mechanisms of actionZena N Willsmore, Ben G T Coumbe, Silvia Crescioli, et al.
NPJ Precision Oncology|March 7, 2026
An antibody-drug conjugate designed through clone and isotype selection restricts the growth of CSPG4-expressing triple-negative breast cancerBenjamina Esapa, Yi Liu, Alicia M Chenoweth, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Scientific Reports|June 3, 2020
Rapid conjugation of antibodies to toxins to select candidates for the development of anticancer Antibody-Drug Conjugates (ADCs)Ricarda M Hoffmann, Silvia Mele, Anthony Cheung, et al.
Frontiers in Immunology|September 30, 2017
Functionally Active Fc Mutant Antibodies Recognizing Cancer Antigens Generated Rapidly at High YieldsKristina M Ilieva, Judit Fazekas-Singer, Daniela Y Achkova, et al.
Cell Reports|May 16, 2019
Integrin-Mediated Macrophage Adhesion Promotes Lymphovascular Dissemination in Breast CancerRachel Evans, Fabian Flores-Borja, Sina Nassiri, et al.
Scientific Reports|July 15, 2016
IgG subclass switching and clonal expansion in cutaneous melanoma and normal skinLouise Saul, Kristina M Ilieva, Heather J Bax, et al.
Journal for Immunotherapy of Cancer|June 11, 2021
Immunotherapy using IgE or CAR T cells for cancers expressing the tumor antigen SLC3A2Giulia Pellizzari, Olivier Martinez, Silvia Crescioli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 21, 2024
Anti-EGFR Antibody-Drug Conjugate Carrying an Inhibitor Targeting CDK Restricts Triple-Negative Breast Cancer GrowthAnthony Cheung, Alicia M Chenoweth, Annelie Johansson, et al.
Frontiers in Immunology|February 11, 2021
B Cells in Patients With Melanoma: Implications for Treatment With Checkpoint Inhibitor AntibodiesZena N Willsmore, Robert J Harris, Silvia Crescioli, et al.
Cell Reports|July 19, 2018
ALIX Regulates Tumor-Mediated Immunosuppression by Controlling EGFR Activity and PD-L1 PresentationJames Monypenny, Hanna Milewicz, Fabian Flores-Borja, et al.
European Journal of Immunology|January 15, 2021
Combined anti-PD-1 and anti-CTLA-4 checkpoint blockade: Treatment of melanoma and immune mechanisms of actionZena N Willsmore, Ben G T Coumbe, Silvia Crescioli, et al.
NPJ Precision Oncology|March 7, 2026
An antibody-drug conjugate designed through clone and isotype selection restricts the growth of CSPG4-expressing triple-negative breast cancerBenjamina Esapa, Yi Liu, Alicia M Chenoweth, et al.
Pageof 5